Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodality Neuromonitoring In eXtreme Lateral Interbody Fusion (XLIF®)

NCT01499680 is registered in ClinicalTrials.gov with NuVasive as lead sponsor.

NCT NCT01499680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01499680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodality Neuromonitoring In eXtreme Lateral Interbody Fusion (XLIF®)
Lead sponsor
NuVasive
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
June 30, 2014
Enrollment
323 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

degeneration of lumbar intervertebral disc